Integrum AB

Equities

INTEG B

SE0009807266

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Stockholm Other stock markets 09:30:00 28/06/2024 pm IST			5-day change	1st Jan Change
54.8 ^SEK	+2.62%		+2.62%	+20.04%

13/06	Integrum AB Signs Memorandum of Understanding with Coapt, LLC for the Use of its Pattern Recognition Technology with the e-OPRA[TM] Implant System	CI
10/06	Integrum AB Enters Collaboration and Distribution Agreement with Hanger	CI

Integrum AB Announces Board Changes

May 19, 2022 at 09:52 pm IST

Integrum AB (publ) announced Rickard Brånemark resigned as Chairman of the Board, and the Board of Directors appointed Bengt Sjöholm as new Chairman. Bengt Sjöholm has a vast experience from the medtech industry and has served as Board Director since 2019.

Latest news about Integrum AB

Integrum AB Signs Memorandum of Understanding with Coapt, LLC for the Use of its Pattern Recognition Technology with the e-OPRA[TM] Implant System	13/06	CI
Integrum AB Enters Collaboration and Distribution Agreement with Hanger	10/06	CI
Integrum AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2024	30/05	CI
Integrum Receives Market Approval for Opra®? Implant System in Israel	29/05	CI
Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu	15/05	CI
Integrum Expands Its Product Offering to the United Kingdom Market	02/05	CI
Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel	26/03	CI
Integrum AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	29/02	CI
Integrum Sells and Delivers Opratm Implant Systems to A Value of SEK 3.5 Million to Center of Excellence in Ukraine	01/02	CI
Integrum AB Establishes Center of Excellence in Ukraine	20/12	CI
Integrum AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	04/12	CI
Integrum AB Plans to Submit a PMA Application to the FDA for the Use of OPRA in Transhumeral Implantations Based on Existing Clinical Data	13/11	CI
Integrum AB Provides Earnings Guidance for the Second Quarter of 2023	10/11	CI
Integrum Announces US Department of Defense Decided to Fully Fund a Clinical Study of OPRA(TM) Implant System on Up to 30 Patients with Transtibial (Below-Knee) Amputations	10/11	CI
Integrum's Opra?? Implant System Gets Fda Approval for Clinical Study on Below-Knee Amutationations	30/23/30	CI
Integrum Enters into the Turkey Market	27/23/27	CI
Integrum Announces Long-Term Follow-Up Patient Who Received A Human-Machine Bionic Hand Prosthesis, Utilizing	12/23/12	CI
Integrum Announces Long-Term Integrated Bionic Hand Enriched with Motor and Sensory AI	12/23/12	CI
Integrum Receives Unitary Patent for Neuromotus in the EU	10/23/10	CI
Integrum AB Appoints Scott Flora as Full Board Member	10/23/10	CI
Integrum Initiates A Strategic Review Process to Accelerate Growth	14/23/14	CI
Integrum AB Receives Reimbursement Code for Axor II	08/23/08	CI
Integrum AB Reports Earnings Results for the First Quarter Ended July 31, 2023	31/23/31	CI
Analysis-Small firms offer private equity job market bright spot	26/23/26	RE
Integrum Announces First Case Study of A Person with Above-Elbow Implantation Obtains Unprecedented Control of Every Finger in A Bionic Hand	13/23/13	CI

Chart Integrum AB

Duration

Period

More charts

Company Profile

Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Companyâs solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patientâs bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/08/2024 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Integrum AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
INTEGRUM AB	+20.04%	10Cr
STRAUMANN HOLDING AG	-17.92%	1.97TCr
COCHLEAR LIMITED	+8.00%	1.45TCr
DEMANT A/S	+1.82%	942.72Cr
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-23.29%	191.03Cr
EMBLA MEDICAL HF.	+7.47%	180.95Cr
ANGELALIGN TECHNOLOGY INC.	+0.35%	122.99Cr
MODERN DENTAL GROUP LIMITED	-.--%	52Cr
ANGEL ROBOTICS CO., LTD.	-.--%	37Cr
DELCATH SYSTEMS, INC.	+101.20%	23Cr

Medical Prosthetics